NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides · page 22 of 25
Includes footnotes regarding anti-dilution provisions and reverse stock split/warrant conversion context.
Pitch deck · appendix_data · analyze_data · dense density
Slide locked Sign in to view
Slide schematic 4/4
disclaimer 1/1 table 2/2 title 1/1
Components 4
disclaimer data valuation headline
Tools 2
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.